BLOOD PRESSURE, CARDIOVASCULAR OUTCOMES AND SODIUM INTAKE, A CRITICAL REVIEW OF THE EVIDENCE

REFERENCES

• Robertson JIS. Dietary salt and hypertension: a scientific issue or a matter of faith? J Eval Clin Pract 2003; 9: 1–22.
   PubMed Web of Science ®Google Scholar
• Alderman MH. Reducing dietary sodium. The case for caution. JAMA 2010; 303: 448–449.
   PubMed Web of Science ®Google Scholar
• Anonymous. Salt and cardiovascular disease mortality. Lancet 2011; 377: 1626.
   Web of Science ®Google Scholar
• Prospective Studies Collaboration. Age-specific relevance of usual blood pres-sure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903–1913.
   PubMed Web of Science ®Google Scholar
• Palar K, Sturm R. Potential societal savings from reduced sodium consumption in the U.S. adult population. Am J Health Promot 2009; 24:49–57.
   PubMed Web of Science ®Google Scholar
• Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. Population strategies to decrease sodium intake and the burden of cardiovascular disease. A cost-effectiveness analysis. Ann Intern Med 2010; 152: 481–487.
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362: 590–599.
   PubMed Web of Science ®Google Scholar
• Staessen J, Bulpitt C, Fagard R, Joossens JV, Lijnen P. Amery A. Four urinary cations and blood pressure. A population study in two Belgian towns. Am J Epidemiol 1983; 117: 676–687.
   PubMed Web of Science ®Google Scholar
• Smith WCS, Crombie IK, Tavendale RT, Gulland SK, Tunstall-Pedoe HD. Urinary electrolyte excretion, alcohol consumption, and blood pressure in the Scottish Heart Health study. BMJ 1988; 297: 329–330.
   PubMed Web of Science ®Google Scholar
• Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012; 25: 1–15.
   PubMed Web of Science ®Google Scholar
• Staessen J, Bulpitt CJ, Fagard R, Joossens JV, Lijnen P. Amery A. Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. J Hypertens 1988; 6: 965–973.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Lijnen P. Thijs L, Fagard R. Salt and blood pressure in community-based intervention trials. Am J Clin Nutr 1997; 65 (suppl): 6615–6705.
   Google Scholar
• Geerling JC, Loewy AD. Central regulation of sodium appetite. Exp Physiol 2008; 93: 177–209.
   Web of Science ®Google Scholar
• Guyton AC. Long-term arterial pressure control: an analysis from animal experiments and computer and graphic models. Am J Physiol 1990; 259: R865–R877.
   Web of Science ®Google Scholar
• Visser FW, Boonstra AH, Titia Lely A, Boomsma F, Navis G. Renal response to angiotensin Ills blunted in sodium-sensitive men. Am J Hypertens 2008; 21:323–328.
   Web of Science ®Google Scholar
• Luft FC. Molecular aspects of genetics of salt-sensitivity and hypertension. Drug Metab Dispos 2003; 29: 500–504.
   Web of Science ®Google Scholar
• Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet 2003; 361:1629–1641.
   PubMed Web of Science ®Google Scholar
• Beretta-Piccoli C, Weidmann P. Brown JJ, Davies DL, Lever AF, Robertson JIS. Body sodium and blood volume state in essential hypertension: abnormal rela-tion of exchangeable sodium to age and blood pressure in male patients. J Car-diovasc Pharmacol 1984; 6 (suppl. 1): S134–5142.
   Web of Science ®Google Scholar
• Titze J, Machnik A. Sodium sensing in the interstitium and the relationship to hypertension. Curr Opin Nephrol Hypertens 2010; 19:385–362.
   PubMed Web of Science ®Google Scholar
• Campese VM. Salt-sensitive hypertension: renal and cardiovascular implica-tions. Nutr Metab Cardiovasc Dis 1999; 9: 143–156.
   Web of Science ®Google Scholar
• Adrogué HJ, Madias NE. Sodium and potassium in the pathogenesis of hyper-tension. N Engl J Med 2007; 356: 1966–1978.
   PubMed Web of Science ®Google Scholar
• Intersalt Cooperative Research Group. Intersalt: an international study of elec-trolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297: 319–328.
   PubMed Web of Science ®Google Scholar
• Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V. Seidlerova J, Richart T, Jin Y, Olszanecka A, Malyutina S, Casiglia E, Filipovsky J, Kawecka-Jaszcz K, Nikitin Y, Staessen JA, on behalf of the European Project on Genes in Hyperten-sion EPOGH) Investigators. Fatal and nonfatal outcomes, incidence of hyperten-sion and blood pressure changes in relation to urinary sodium excretion in White Europeans. JAMA 2011; 305: 1777–1785.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Appel U, Espeland MA, Applegate WB, Ettinger WH, Jr., KostisJB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA, for the TONE Collabora-tive Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons. A randomized controlled trial of nonpharmaco-logic interventions in the elderly (TONE). JAMA 1998; 279: 839–846.
   PubMed Web of Science ®Google Scholar
• Grobbee DE, Hofman A. Does sodium restriction lower blood pressure? BMJ 1986; 293: 27–29.
   PubMed Web of Science ®Google Scholar
• Midgley JP, Matthew AG, Greenwood CMT, Logan AG. Effect of reduced dietary sodium on blood pressure. A meta- analysis of randomized controlled trials. JAMA 1996; 275: 1590–1597.
   PubMed Web of Science ®Google Scholar
• Cutler JA, Follmann DF, Allender PS. Randomized trials of sodium reduction: an overview. Am J Clin Nutr 1997; 65 (suppl): 6435–6515.
   Google Scholar
• He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004; Issue 3. Art. No.: CD004937.
   Google Scholar
• He J, Whelton PK, Appel U, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000; 35: 544–549.
   PubMed Web of Science ®Google Scholar
• Chien KL, Hsu HC, Chen PC, Su TC, Chang WT, Chen MF, Lee YT. Urinary sodium and potassium excretion and risk of hypertension in Chinese: report from a community-based cohort study in Taiwan. J Hypertens 2008; 26: 1750–1756.
   Web of Science ®Google Scholar
• Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P. Pingard AM, Shade R, Carey D, Ardaillou R, Paillard F, Chapman J, Thillet J, Michel JB. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1995; 1: 1009–1016.
   PubMed Web of Science ®Google Scholar
• Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hyper-tensive men. Hypertension 1995; 25: 1144–1152.
   PubMed Web of Science ®Google Scholar
• Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and woman of the Scottish Heart Health Study: cohort study. BMJ 1997; 315: 722–729.
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Jousilahti P. Rastenyte D, Moitchanov V, Tanskanen A, Pietinen P. Nissinen A. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001; 357: 848–851.
   PubMed Web of Science ®Google Scholar
• Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel U, Whelton PK, for the Trials of Hypertension Prevention Collaborative Research Group. Long term effects of dietary sodium reduction on cardiovas-cular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334: 885–888.
   PubMed Web of Science ®Google Scholar
• Cook NR, Obarzanek E, Cutler JA, Buring JE, Rexrode KM, Kumanyika SK, Appel U, Whelton PK, for the Trials of Hypertension Prevention Collaborative Research Group. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention (TOHP) follow-up study. Arch Intern Med 2009; 169: 32–40.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhäger WH, Herrmann SM, Fagard R, Tizzoni L, Bianchi G. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 2001; 19: 1349–1358.
   PubMed Web of Science ®Google Scholar
• Kuznetsova T, Staessen JA, Kawecka-Jaszcz K, Babeanu S, Casiglia E, Filipovsky J, Nachev C, Nikitin Y, Peleäka J, O'Brien E, on behalf of the EPOGH Investigators. Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press Monit 2002; 7: 215–224.
   PubMed Web of Science ®Google Scholar
• Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Wadén J, Tolo-nen N, Saraheimo M, Gordin D, Groop PH, for the FinnDiane Study Group. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabet Care 2011; 34: 861–866.
   PubMed Web of Science ®Google Scholar
• Ekinci EL, Clarke S, Thomas MC, Moran JL, Cheong K, Maclsaac RJ, Jerums G. Dietary salt intake and mortality in patients with type 2 diabetes. Diabet Care 2011; 34: 703–709.
   PubMed Web of Science ®Google Scholar
• Kagan A, Popper JS, Rhoads GG,Yano K. Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke 1985; 16: 390–396.
   PubMed Web of Science ®Google Scholar
• He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999; 282: 2027–2034.
   PubMed Web of Science ®Google Scholar
• Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES l). Lancet 1998; 351: 781–785.
   PubMed Web of Science ®Google Scholar
• Cohen HW, Hailpern SM, Alderman MH. Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). J Gen Intern Med 2008; 23: 1297–1302.
   Web of Science ®Google Scholar
• Cohen HW, Hailpern SM, Fang J, Alderman MH. Sodium intake and mortality in the NHANES II follow-up study. Am J Med 2006; 119: 275.e7-275.e14.
   Web of Science ®Google Scholar
• Geleijnse JM, Witteman JCM, Stijnen T, Kloos MW, Hofman A, Grobbee DE. Sodium and potassium intake and risk of cardiovascular events and all-cause mortality: the Rotterdam study. Eur J Epidemiol 2007; 22: 763–770.
   PubMed Web of Science ®Google Scholar
• Umesawa M, lso H, Date C, Yamamoto A, toyoshima H, Watanabe Y, Kikuchi S, Koizumi A, Kondo T, Inaba Y, Tanabe N, Tamakoshi A, the JACC Study Group. Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: the Japan Collaborative Cohort Study for Evaluation of Cancer Risks. Am J Clin Nutr 2008; 88: 195–202.
   PubMed Web of Science ®Google Scholar
• Yang Q, Liu T, Kuklina E, Flanders D, Hong Y, Gillespie C, Chang MH, Gwinn M, Dowling N, Khoury MJ, Hu FB. Sodium and potassium intake and mortality among US adults. Arch Intern Med 2011; 171:1183–1191.
   PubMed Web of Science ®Google Scholar
• O'Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma AM, Dans A, Probstfield J, Schmieder RE. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011; 306: 2229–2238.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Anderson C, ONTARGET Investigators. Telmisa rtan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547–1559.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. TRANSCEND Investigators. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised con-trolled trial. Lancet 2008; 372: 1174–1183.
   PubMed Web of Science ®Google Scholar
• Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized con-trolled trials (Cochrane Review). Am J Hypertens 2011; 115: 1–10.
   Google Scholar
• Strazzullo P. D'Elia L, Kandala NB, Cappuccio FR Salt intake, stroke, and cardio-vascular disease: meta-analysis of prospective studies. BMJ 2009; 339: b4567.
   PubMed Web of Science ®Google Scholar
• Grassi G, Dell'Oro R, Seravalle G, Foglia G, Trevano FQ, Mancia G. Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension. Circulation 2002; 106: 1957–1961.
   PubMed Web of Science ®Google Scholar
• Garg K, Williams GH, Hurwitz S, Brown NJ, Hopkins PN, Adler GK. Low-salt diet increases insulin resistance in healthy subjects. Metabolism 2011; 60: 965–968.
   PubMed Web of Science ®Google Scholar
• Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324: 1098–1104.
   PubMed Web of Science ®Google Scholar
• Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SCJ, Vafiadis DK, Van Horn LV. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke. A call to action from the American Heart Association. Circulation 2011; 123: 1138–1143.
   PubMed Web of Science ®Google Scholar